Is Journal of Immunology Indexed in PubMed? Yes, With Deep Archive Support
The Journal of Immunology is indexed in PubMed and currently indexed for MEDLINE, with coverage from 1965 plus Core Clinical Journals and OLDMEDLINE support.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Journal of Immunology at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 3.4 puts Journal of Immunology in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~40-50% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Journal of Immunology takes ~~90-120 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick answer: yes. **The Journal of Immunology is indexed in PubMed and currently indexed for MEDLINE, with active indexed coverage from volume 95, issue 2 in August 1965 plus OLDMEDLINE and Core clinical journals support.
** That means the discoverability story is stronger than a plain yes.
The title has field depth, archive continuity, and enough clinical-adjacent relevance to sit inside AIM as well as Index Medicus.
Direct answer
If you publish in The Journal of Immunology, your paper is discoverable in PubMed and the journal remains actively indexed for MEDLINE.
NLM field | What the record shows | Why it matters |
|---|---|---|
publication start under current title | 1950 | the journal predates its active indexed coverage line |
PubMed coverage | v95n2, Aug. 1965- | current searchable coverage begins in 1965 |
MEDLINE coverage | v95n2, Aug. 1965- | curated indexing begins on the same line |
archive signals | OLDMEDLINE | older literature still has historical search support |
current subset | Index Medicus; Core clinical journals (AIM) | the title sits in both field and clinical-adjacent reading systems |
current indexing status | Currently indexed for MEDLINE | active indexing remains intact |
That is a strong indexing profile for a long-running society flagship in immunology.
Why this matters for The Journal of Immunology
The journal occupies an interesting middle ground. It is fundamentally an immunology title, but its papers often travel into:
- infection and host defense
- inflammation and autoimmunity
- cancer immunology
- translational immune mechanism
- clinician-facing immune-disease reading
That is why the AIM line matters here. The journal is not only visible in PubMed. It also sits close enough to practical clinical reading behavior to land in the Core clinical journals subset.
What the indexing record tells you in practice
Practical question | What the record tells you |
|---|---|
will a new paper be searchable in PubMed? | yes |
is the journal actively indexed for MEDLINE? | yes |
does the active indexed line begin at the 1950 launch? | no |
does the archive still have extra historical support? | yes, via OLDMEDLINE |
does this prove the manuscript belongs in The Journal of Immunology? | no |
That combination of archive depth and clinical-adjacent indexing is the unusual part.
PubMed, MEDLINE, AIM, and OLDMEDLINE all matter here
For The Journal of Immunology, these lines carry different information:
- PubMed means papers are visible in the main biomedical search interface.
- MEDLINE means the title remains in the curated NLM journal index.
- Core clinical journals (AIM) means the journal is close enough to clinical immunology workflows to matter there.
- OLDMEDLINE reinforces historical archive continuity.
For a field journal with long society lineage, that is valuable context. It tells you the journal is not only searchable. It is deeply embedded in the immune-literature system.
How this compares with nearby immunology journals
Journal pattern | What the indexing record usually supports | What it does not solve |
|---|---|---|
long-running society flagship like The Journal of Immunology | deep archive continuity plus clinical-adjacent visibility | whether the paper is strong enough for the venue |
broad OA immunology journal | wide search visibility and access | whether the editorial model fits your paper |
high-end mechanistic flagship | strong prestige and search presence | whether your work is deep enough |
So yes, the indexing record here is better than average. It still does not determine submission strategy by itself.
How to verify the record yourself
To verify the indexing manually:
- open the NLM Catalog record
- confirm the PubMed line
- confirm the MEDLINE line
- check Current Subset
- note OLDMEDLINE
- run a journal-title search in PubMed
For this title, the important part is reading the archive lines literally. The publication history begins earlier than the active indexed coverage line.
What we see in PubMed-indexing questions for The Journal of Immunology
For PubMed-indexing questions for The Journal of Immunology, three patterns come up repeatedly.
The field-journal underestimate. Some authors assume a field-specific title must have weaker discoverability than broader journals. For this title, that is too simplistic. The AIM and OLDMEDLINE signals show more infrastructure depth than many people expect.
The archive-start confusion. We often see authors assume indexing must run from the 1950 title start. The NLM record does not say that. The active PubMed and MEDLINE lines begin in August 1965.
The indexing-equals-fit mistake. Another common error is using the strong archive record as if it proves the paper belongs here. It does not. The work still has to be right for the journal's field-level scope and expectations.
That is the useful information gain here. The discoverability profile is stronger than a plain yes, but it still does not answer the editorial-fit question.
What the NLM record means in practice for authors
The Journal of Immunology NLM record tells you that a published paper will be visible in the main biomedical search workflow and supported by active MEDLINE indexing. That part is straightforward.
The more interesting part is the combination of AIM and OLDMEDLINE. Together, those signals tell you the title has both historical depth and enough clinical-adjacent value to sit close to practical immune-disease reading patterns. That is stronger than what many field journals get.
But the record also tells you what it cannot answer. It cannot tell you whether the manuscript should go here, to a broader immunology flagship, or to a narrower specialty venue. That is still a fit question.
Why the archive line matters more here than on many other pages
For some journals, OLDMEDLINE is a technical footnote. For The Journal of Immunology, it has more practical weight because older immune literature still gets used in several real workflows:
- mechanism reviews that trace how a cell type or signaling idea developed
- disease-background sections in grants and review articles
- translational papers that still cite foundational immunology experiments
That does not mean every old paper is equally useful, but it does mean the archive signal is not decorative. It reinforces that the journal behaves like a long-running field backbone rather than a title with only recent visibility.
What indexing does and does not tell you
This page answers the discoverability question. It does not answer whether The Journal of Immunology is the right venue for your paper.
Indexing tells you:
- the paper will be visible in PubMed
- the journal is actively indexed for MEDLINE
- the archive is supported by OLDMEDLINE
- the title sits in both AIM and Index Medicus
Indexing does not tell you:
- whether the work is strong enough
- whether the scope is right
- whether a broader or narrower immunology title would fit better
That is why the more useful next pages are:
- Is my paper ready for Journal of Immunology?
If the fit question is what you actually need answered, a Journal of Immunology submission readiness check is the right next step before submission.
Submit If / Think Twice If
Use this indexing answer as enough reassurance if:
- your concern is PubMed discoverability
- you want confirmation of active MEDLINE indexing
- you care about archive support and clinical-adjacent visibility
Think twice if:
- you are treating indexing as proof of fit
- you were assuming the active indexed line starts in 1950
- what you really need is a field-positioning judgment rather than a metadata answer
If the fit question is what you actually need answered, a Journal of Immunology submission readiness check gives you a manuscript-specific signal before you submit.
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Practical verdict
Yes, The Journal of Immunology is indexed in PubMed and currently indexed for MEDLINE, with active indexed coverage from August 1965 plus OLDMEDLINE and Core clinical journals support.
If your question is whether a published paper will be visible in the biomedical search workflow, the answer is yes. If your real question is whether the journal is the right field-level home for your manuscript, that is a separate submission decision.
Or see example reports before you finalize.
Frequently asked questions
Yes. The Journal of Immunology is indexed in PubMed and currently indexed for MEDLINE according to the NLM Catalog.
The NLM Catalog shows PubMed and MEDLINE coverage from volume 95, issue 2 in August 1965, with OLDMEDLINE support also listed.
Yes. The NLM Catalog lists Core clinical journals (AIM) as well as Index Medicus.
Open the journal's NLM Catalog record, check the current indexing status plus the PubMed, MEDLINE, and current subset lines, and confirm recent papers appear normally in PubMed.
Sources
- 1. The Journal of Immunology NLM Catalog record, NLM.
- 2. NLM Catalog help: current indexing status, NLM.
- 3. The Journal of Immunology journal page, OUP / AAI.
- 4. The Journal of Immunology instructions for authors, OUP / AAI.
- 5. The Journal of Immunology in PubMed, PubMed.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Journal of Immunology Submission Guide: What Editors Screen Before Review
- How to Avoid Desk Rejection at Journal of Immunology (2026)
- Journal of Immunology APC and Open Access: Current AAI/OUP Fees and What Authors Actually Pay
- Journal of Immunology Formatting Requirements: The Submission Package Guide
- Journal of Immunology Review Time: What Authors Can Actually Expect
- Journal of Immunology Impact Factor 2026: 3.4, Q2, Rank 85/183
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.